Le Lézard
Classified in: Health
Subjects: PDT, TDS

Biologica Technologies® showcases AMP aesthetictm at Plastic Surgery The Meeting 2017

CARLSBAD, Calif., Oct. 6, 2017 /PRNewswire/ -- Biologica Technologies, developers and marketers of Allofill®, announced today that they will be introducing AMP aesthetic at the upcoming Plastic Surgery The Meeting, the annual conference hosted by the American Society of Plastic Surgeons (ASPS).

AMP aesthetic is the first product of its kind, an allogeneic-derived growth factor that can be used in the same manner as platelet rich plasma (PRP). The product contains a full cascade of growth factors, including but not limited to; PDGF, TGF-?1, and VEGF. In comparison with market leading PRP systems and the PRP processed, AMP aesthetic possesses sufficiently higher growth factor amounts. Additionally, when AMP aesthetic is combined with autologous fat transfer (AFT), early data has exhibited higher graft retention than AFT alone.

"AMP aesthetic continues our company's commitment of bringing cutting edge tissue-based technologies to the field of aesthetics," stated Scott Cadotte, Vice President of Sales & Marketing of Biologica Technologies. "It provides a cost-effective 'off the shelf' option for plastic surgeons and their patients."

About Biologica Technologies
Founded in 2015, Biologica Technologies is a privately-held company fully dedicated to improving patients' lives and the health care providers' experience through innovative biologic solutions. Their first aesthetic product, Allofill, is an adipose-derived filler containing naturally occurring growth factors that can be used to fill soft-tissue defects as a noninvasive alternative to autologous fat grafting. The company is headquartered in Carlsbad, CA.

Related Links


SOURCE Biologica Technologies

These press releases may also interest you

at 07:33
VitalHub Corp. (the "Company" or "VitalHub") is pleased to announce subsidiary company B Sharp's Sri Lankan development arm "B Sharp Lanka" is in the process of renaming itself "VitalHub (Pvt) Ltd." This change in name reflects a shift toward...

at 07:32
Bionik Laboratories Corp. ("Bionik" or the "Company"), a global robotics company focused on providing rehabilitation and assistive technology solutions from hospital to home for individuals with neurological and mobility challenges, today announced...

at 07:30
ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced the appointment of Sharon Cohen, MD, to the Company's scientific advisory board...

at 07:22
Implantcenter, an affordable dentistry and oral surgery in central London, successfully placed its 28,000th implant in a bid to reach 30,000 by the end of the year. The clinic is marking the milestone by offering special prices and packages.     ...

at 07:05
RXi Pharmaceuticals Corporation a biotechnology company developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform announced today that Dr. Geert Cauwenbergh, RXi's President and CEO, will...

at 07:03
NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, announced today the appointment of George Cardoza as President of the Pharma Services Division and Sharon Virag as Chief Financial Officer. Ms. Virag will succeed...

News published on 6 october 2017 at 07:45 and distributed by: